Abstract
Due to the lack of structural guidelines about G-quadruplex ligands, rational design cannot be the only approach to discover potent G4-ligands. As a complementary approach, screening of chemical library may provide interesting scaffolds known as hits provided that specific tools are available. In this work, the Institut Curie-CNRS chemical library was firstly screened by chemoinformatics methods. Similarity estimations by comparison with reference compounds (Phen-DC3, 360A, MMQ12) provided a set of molecules, which were then evaluated by high-throughput G4-FID (HT-G4-FID) against various G-quadruplex DNA. A full investigation of the most interesting molecules, using the HT-G4-FID assay and molecular modeling, supplied an interesting structure-activity relationship confirming the efficiency of this general approach. Overall, we demonstrated that HT-G4-FID coupled with screening of chemical libraries is a powerful tool to identify new G4-DNA binding scaffolds.
Keywords: G-quadruplex DNA, FID assay, high-throughput, screening, fluorescence, G-quadruplex ligands, thiazole orange, molecular modeling, HT-G4-FID, chemoinformatics
Current Pharmaceutical Design
Title:Screening of a Chemical Library by HT-G4-FID for Discovery of Selective G-quadruplex Binders
Volume: 18 Issue: 14
Author(s): Eric Largy, Nicolas Saettel, Florian Hamon, Sylvie Dubruille and Marie-Paule Teulade-Fichou
Affiliation:
Keywords: G-quadruplex DNA, FID assay, high-throughput, screening, fluorescence, G-quadruplex ligands, thiazole orange, molecular modeling, HT-G4-FID, chemoinformatics
Abstract: Due to the lack of structural guidelines about G-quadruplex ligands, rational design cannot be the only approach to discover potent G4-ligands. As a complementary approach, screening of chemical library may provide interesting scaffolds known as hits provided that specific tools are available. In this work, the Institut Curie-CNRS chemical library was firstly screened by chemoinformatics methods. Similarity estimations by comparison with reference compounds (Phen-DC3, 360A, MMQ12) provided a set of molecules, which were then evaluated by high-throughput G4-FID (HT-G4-FID) against various G-quadruplex DNA. A full investigation of the most interesting molecules, using the HT-G4-FID assay and molecular modeling, supplied an interesting structure-activity relationship confirming the efficiency of this general approach. Overall, we demonstrated that HT-G4-FID coupled with screening of chemical libraries is a powerful tool to identify new G4-DNA binding scaffolds.
Export Options
About this article
Cite this article as:
Largy Eric, Saettel Nicolas, Hamon Florian, Dubruille Sylvie and Teulade-Fichou Marie-Paule, Screening of a Chemical Library by HT-G4-FID for Discovery of Selective G-quadruplex Binders, Current Pharmaceutical Design 2012; 18 (14) . https://dx.doi.org/10.2174/138161212799958350
DOI https://dx.doi.org/10.2174/138161212799958350 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Pharmacological Review of Five Widely Used Traditional Medicinal Plants for Sedative-Hypnotic Effects in Bangladesh
Current Traditional Medicine Fluorescence Imaging in Cancerology
Current Molecular Imaging (Discontinued) Individual Differences in Novelty-Seeking and Behavioral Responses to Nicotine: A Review of Animal Studies
Current Drug Abuse Reviews Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules
Current Drug Targets A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury
Current Neuropharmacology An Approach to Treatment of Liver Cancer by Novel Glycyrrhizin Derivative
Anti-Cancer Agents in Medicinal Chemistry Preface
Current Radiopharmaceuticals Mitochondrial Functionality and Chemical Compound Action on Sperm Function
Current Medicinal Chemistry Prevalence of Cardiovascular and Metabolic Events in Patients Prescribed Clozapine: A Retrospective Observational, Clinical Cohort Study
Current Drug Safety Editorial [ Hot Topic: Antidepressant Drug Design (Executive Editor: Lee E. Schechter)]
Current Pharmaceutical Design Brain Aging in African-Americans: The Atherosclerosis Risk in Communities (ARIC) Experience
Current Alzheimer Research Targeting the Pleiotrophin/Receptor Protein Tyrosine Phosphatase β /ζ Signaling Pathway to Limit Neurotoxicity Induced by Drug Abuse
Mini-Reviews in Medicinal Chemistry Body Dysmorphic Disorder in Adolescents
Adolescent Psychiatry Formulation and In Vitro Evaluation of Gelatin Nanospheres for the Oral Delivery of Selegiline
Current Nanoscience Melatonin Receptor Antagonist Luzindole: A Facile New Synthesis
Letters in Organic Chemistry The Association Between Alcohol Use and Sexual Risk Behaviors Among African American Women Across Three Developmental Periods: A Review
Current Drug Abuse Reviews Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease
Current Cardiology Reviews Non-Antidepressant Psychopharmacologic Treatment of Specific Phobias
Current Clinical Pharmacology Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese
Current Neuropharmacology Current Opinions and Perspectives on the Role of Immune System in the Pathogenesis of Parkinson's Disease
Current Pharmaceutical Design